Clinical trials: New opportunities

Sandra Bond Chapman, Carl W. Cotman, Howard M. Fillit, Michela Gallagher, Christopher H. Van Dyck

Research output: Contribution to journalArticlepeer-review

Abstract

Human cognitive aging has been too long neglected and underappreciated for its critical importance to quality of life in old age. The articles in this session present novel approaches to improving cognitive function in normal aging persons with drugs and interventions that are based on findings in epidemiology, studies in aged animals, and in vitro research. In addition, since aging is the primary risk factor for Alzheimer's disease, these studies also have implications as interventions for prevention and treatment. As a field of research, new knowledge regarding the causes and mechanisms of cognitive aging are ripe for translation into human studies, with the application of this knowledge leading the development of interventions and therapeutics for the prevention of cognitive decline in old age and Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)773-780
Number of pages8
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume67 A
Issue number7
DOIs
StatePublished - Jun 15 2012

Keywords

  • Alzheimers
  • Clinical trial
  • Cognition
  • Cognitive aging

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Clinical trials: New opportunities'. Together they form a unique fingerprint.

Cite this